Search Results 791-800 of 38074 for Two-phase

1. A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

   Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

3. A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

   This is a Phase 2, single-arm, open-label, multicenter study evaluating efficacy, safety and tolerability of navitoclax added to ruxolitinib in participants ...

4. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

   The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

5. PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL) (PACIFICA) - Mayo Clinic

   PMF, PPV-MF, or PET-MF (as defined by Tefferi and Vardiman 2008). · Platelet count of <50,000/μL at Screening (Day -35 to Day -3) (based on two measurements ...

6. Publications - Matthew P. Abdel, M.D. - Mayo Clinic

   Modular fluted tapered stems in two-stage reimplantation of previously infected total hip arthroplasties. Bone Joint J. 2024 May 1; 106-B (5 Supple B):125 ...

7. Plasma Cell Disorders Clinical Trials - Mayo Clinic Research

   This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior systemic treatment for ...

8. Squamous Cell Carcinoma Of The Skin Clinical Trials - Mayo Clinic Research

   A Phase Ib/II Study of BYL719 and Cetuximab in ... two different arms using two different ... (Stage I and Stage II). Additinoally, to evaluate the ...

9. VE303 for Prevention of Recurrent Clostridioides Difficile Infection (RESTORATiVE303) - Mayo Clinic

   The objectives and endpoints are identical for Stage 1 (recurrent CDI) and Stage 2 (high-risk primary CDI). Only adults will be enrolled at Mayo Clinic Arizona ...

10. Neuroendocrine Tumors Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the safety and tolerability of AMG 757, and to determine the maximum tolerated dose (MTD) or recommended phase 2 dose ( ...